Kawanishi Koki, Kato Jun, Kakimoto Tetsuhiro, Hara Takeshi, Yoshida Takeichi, Ida Yoshiyuki, Maekita Takao, Iguchi Mikitaka, Kitano Masayuki
Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.
Department of Gastroenterology, Wakayama Rosai Hospital, Wakayama, Japan.
Endosc Int Open. 2018 Jan;6(1):E36-E42. doi: 10.1055/s-0043-122494. Epub 2018 Jan 12.
Re-commencement of bleeding (rebleeding) of colonic diverticula after endoscopic hemostasis is a clinical problem. This study aimed to examine whether endoscopic visibility of colonic diverticular bleeding affects the risk of rebleeding after endoscopic hemostasis.
We performed a retrospective review of endoscopic images and medical charts of patients with colonic diverticular bleeding who underwent endoscopic hemostasis. Endoscopic visibility was classified into two types according to visibility of the source of bleeding; source invisibility due to bleeding or attached hematin (type 1), or endoscopically visible responsive vessels (type 2). Rebleeding rates within one year after initial hemostasis were examined.
Of 93 patients with successful endoscopic hemostasis, 38 (41 %) showed type 1 visibility, while the remaining presented type 2. All patients received hemostasis with clipping, rebleeding developed in 20 patients (22 %). Type 1 visibility was more likely to be observed in patients with rebleeding (65 % vs. 34 %, = 0.013). Multivariate analysis revealed that after endoscopic hemostasis, type 1 visibility (invisible source) was the only independent risk factor for colonic diverticular rebleeding (odds ratio, 3.05; 95 % confidence interval, 1.03 - 9.59, = 0.044). Kaplan-Meier curve showed the cumulative incidence of rebleeding was significantly higher in patients with type 1 visibility than those with type 2 visibility ( = 0.0033, log-rank test).
Hemostasis by clipping for colonic diverticular bleeding without definite observation of the source of bleeding may not be sufficiently effective. Other hemostatic methods, including band ligation, should be considered when the source of bleeding is unclear.
结肠憩室内镜止血后再出血是一个临床问题。本研究旨在探讨结肠憩室出血的内镜可视性是否会影响内镜止血后再出血的风险。
我们对接受内镜止血的结肠憩室出血患者的内镜图像和病历进行了回顾性研究。根据出血源的可视性,内镜可视性分为两种类型;因出血或附着血凝块导致的出血源不可见(1型),或内镜可见的反应性血管(2型)。我们检查了初次止血后一年内的再出血率。
在93例内镜止血成功的患者中,38例(41%)表现为1型可视性,其余患者表现为2型。所有患者均接受了夹子止血,20例患者(22%)出现了再出血。再出血患者中更易观察到1型可视性(65%对34%,P = 0.013)。多因素分析显示,内镜止血后,1型可视性(不可见出血源)是结肠憩室再出血的唯一独立危险因素(比值比,3.05;95%置信区间,1.03 - 9.59,P = 0.044)。Kaplan-Meier曲线显示,1型可视性患者的再出血累积发生率显著高于2型可视性患者(P = 0.0033,对数秩检验)。
对于结肠憩室出血,在未明确观察到出血源的情况下使用夹子止血可能效果不够理想。当出血源不明确时,应考虑包括套扎在内的其他止血方法。